Quantcast

 

MedImmune, Novavax debate vaccines (access required)

Posted: 6:47 pm Thu, October 15, 2009
By Danielle Ulman

Two Maryland biotechnology firms began working feverishly in April to formulate swine flu vaccines — one through classic methods that produced a usable vaccine and the other with newer technology that could speed production in the face of a pandemic. Gaithersburg-based MedImmune Inc. developed a swine flu version of its FluMist nasal spray vaccine through traditional ...

Comments

Comments are closed.